Pet Vaccines Market
完整報告名稱與涵蓋範圍
Pet Vaccines Market Size, Share & Trends Analysis Report, By Vaccine Type (Core Vaccines (Distemper, Parvovirus, Rabies, Feline Panleukopenia and Others), Non-Core and Lifestyle Vaccines (Leptospirosis, Bordetella, Lyme, Feline Leukemia), Combination and Multivalent Vaccines), By Technology (Live Attenuated and Inactivated Vaccines, Recombinant, Subunit and Vector-Based Vaccines, Nucleic Acid and Next-Generation Vaccines), By Animal Type (Dogs, Cats, Other Companion Animals), By End User, By Region, and Segment Forecasts, 2026-2035
報告摘要
The pet vaccines market covers core, non-core and combination vaccines for dogs, cats and other companion animals, spanning live attenuated, inactivated, recombinant, vector-based and emerging nucleic acid technologies, administered through veterinary clinics, shelters and vaccination programs. Livestock vaccines and companion animal pharmaceuticals other than vaccines are excluded.
Vaccination is the entry point for preventive pet care, and demand is driven by rising pet populations, guideline-based schedules, rabies control mandates and awareness of emerging threats such as leptospirosis and canine influenza. Manufacturers are extending duration of immunity, developing multivalent combinations that reduce injection burden, applying recombinant and vector technologies that improve safety for cats and dogs, and introducing needle-free and oral delivery. Veterinary corporate consolidation, wellness plans that bundle vaccines and the growth of low-cost vaccination clinics influence pricing and volumes, while cold-chain logistics and regulatory harmonisation affect supply in emerging markets.
North America and Europe account for most revenue, with Asia Pacific growing fastest through rising pet ownership in China, Japan and South Korea and Latin America expanding through rabies and core vaccination programs. Competition is concentrated among global animal health leaders, complemented by regional vaccine producers.
The InsightAce study delivers revenue forecasts in US$ across all vaccine type, technology, animal type and end user and regional segments for 2026-2035, alongside segment-level trend analysis, competitive landscape assessment and detailed company profiling.
授權報價
| Single User | $4,500 USD |
| Enterprise / Global Site Licence | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Pet Vaccines Market Snapshot
Chapter 4. Global Pet Vaccines Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Market Drivers
4.3. Market Challenges
4.4. Emerging Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis - Porter's Five Forces Analysis
4.7. Competitive Landscape and Market Positioning
4.8. Market Opportunity Analysis
Chapter 5. Market Segmentation 1: By Vaccine Type Estimates & Trend Analysis
5.1. Vaccine Type & Market Share, 2026 & 2035
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Vaccine Type:
5.2.1. Core Vaccines (Distemper, Parvovirus, Rabies, Feline Panleukopenia and Others)
5.2.2. Non-Core and Lifestyle Vaccines (Leptospirosis, Bordetella, Lyme, Feline Leukemia)
5.2.3. Combination and Multivalent Vaccines
Chapter 6. Market Segmentation 2: By Technology Estimates & Trend Analysis
6.1. Technology & Market Share, 2026 & 2035
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Technology:
6.2.1. Live Attenuated and Inactivated Vaccines
6.2.2. Recombinant, Subunit and Vector-Based Vaccines
6.2.3. Nucleic Acid and Next-Generation Vaccines
Chapter 7. Market Segmentation 3: By Animal Type Estimates & Trend Analysis
7.1. Animal Type & Market Share, 2026 & 2035
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Animal Type:
7.2.1. Dogs
7.2.2. Cats
7.2.3. Other Companion Animals
Chapter 8. Market Segmentation 4: By End User Estimates & Trend Analysis
8.1. End User & Market Share, 2026 & 2035
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by End User:
8.2.1. Veterinary Clinics and Hospitals
8.2.2. Animal Shelters and Welfare Organizations
8.2.3. Mobile and Retail Vaccination Clinics
Chapter 9. Pet Vaccines Market: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. United States
9.1.2. Canada
9.2. Europe
9.2.1. Germany
9.2.2. United Kingdom
9.2.3. France
9.2.4. Italy
9.2.5. Spain
9.2.6. Rest of Europe
9.3. Asia Pacific
9.3.1. China
9.3.2. Japan
9.3.3. India
9.3.4. South Korea
9.3.5. Australia
9.3.6. Southeast Asia
9.3.7. Rest of Asia Pacific
9.4. Latin America
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Rest of Latin America
9.5. Middle East & Africa
9.5.1. GCC Countries
9.5.2. South Africa
9.5.3. Rest of Middle East & Africa
Chapter 10. Competitive Landscape
10.1. Company Market Positioning Analysis
10.2. Strategic Developments (Partnerships, Expansions, Product Launches, M&A)
Chapter 11. Company Profiles
11.1. Zoetis Inc.
11.2. Merck Animal Health (MSD Animal Health)
11.3. Boehringer Ingelheim Animal Health
11.4. Elanco Animal Health Incorporated
11.5. Virbac S.A.
11.6. Ceva Sante Animale
11.7. Hipra S.A.
11.8. Bioveta, a.s.
11.9. Biogenesis Bago S.A.
11.10. Vetoquinol S.A.
11.11. Indian Immunologicals Limited
11.12. China Animal Husbandry Industry Co., Ltd.
11.13. Kyoritsu Seiyaku Corporation
11.14. Nisseiken Co., Ltd.
11.15. Ourofino Saude Animal
圖表清單 List of Tables & Figures
Table 1. Global Pet Vaccines Market Revenue Forecast by Vaccine Type, 2026-2035 (US$ Mn)
Figure 1. Global Pet Vaccines Market Segmentation Overview
Table 2. Global Pet Vaccines Market Revenue Forecast by Technology, 2026-2035 (US$ Mn)
Figure 2. Global Pet Vaccines Market Share by Vaccine Type, 2026 & 2035
Table 3. Global Pet Vaccines Market Revenue Forecast by Animal Type, 2026-2035 (US$ Mn)
Figure 3. Core and Non-Core Vaccination Coverage Rates by Species and Region
Table 4. Global Pet Vaccines Market Revenue Forecast by End User, 2026-2035 (US$ Mn)
Figure 4. Global Pet Vaccines Market Share by Technology, 2026 & 2035
Table 5. North America Pet Vaccines Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 5. Vaccine Technology Evolution in Companion Animals: Live, Recombinant and Next-Generation Platforms
Table 6. Europe Pet Vaccines Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 6. Asia Pacific Pet Vaccines Growth Opportunity Analysis
Table 7. Asia Pacific Pet Vaccines Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 7. Channel Mix Across Veterinary Clinics, Shelters and Low-Cost Vaccination Programs
Table 8. Latin America Pet Vaccines Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 8. Competitive Positioning of Key Pet Vaccines Market Participants
Table 9. Middle East & Africa Pet Vaccines Market Revenue by Country, 2026-2035 (US$ Mn)
提及公司
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們